¥3.78   ( %)
前日收盘: 当日成交量(股): 当日最高: 总股本:999.86万
当日开盘: 当日成交额(元): 当日最低: 流通股本:
市盈率(动/静):0/0 市净率:0 市销率:0 总市值:3779.49万
52周最高:10.74 52周最低:2.94 转让方式: 单位:美元
$EYENOVIA(EYEN)$
  • 还可以输入
  • 20016

EYENOVIA(EYEN) 10月07日 22时52分

新闻 Johnson Fistel Announces Investigations of PPDAI Group Inc., Menlo Therapeutics Inc., Eyenovia, Inc. and Dragon Victory International Limited; Investors with Losses Encou ......  url.vc.watch/JA0c
查看全文

EYENOVIA(EYEN) 09月29日 02时20分

公告 EYENOVIA, INC. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Rowe Michael M
公告日:2018-09-26, 内部交易人:Rowe Michael M, 与发行人关系:Vice President of Marketing/高管/, 操作:买入,800(股)Common Stock, par value $.0001,均价$4.2250; 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-09-24, SEC Accession No. 0001638599-18-001126, File:https://www.sec.gov/Archives/edgar/data/1682639/000163859918001126/0001638599-18-001126-index.htm $EYENOVIA(EYEN)$
查看全文

EYENOVIA(EYEN) 09月21日 20时02分

公告 EYENOVIA, INC. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:MATHER CHARLES E IV
公告日:2018-09-20, 内部交易人:MATHER CHARLES E IV, 与发行人关系:董事/, 操作:买入,4000(股)Common Stock, par value $.0001,均价$4.7850; 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-09-18, SEC Accession No. 0001638599-18-001117, File:https://www.sec.gov/Archives/edgar/data/1682639/000163859918001117/0001638599-18-001117-index.htm $EYENOVIA(EYEN)$
查看全文

EYENOVIA(EYEN) 09月20日 20时18分

公告 EYENOVIA, INC. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Clasby Jennifer G
公告日:2018-09-18, 内部交易人:Clasby Jennifer G, 与发行人关系:VP, Clinical Operations/高管/, 操作码:M,28965(股)Common Stock; 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-09-10, SEC Accession No. 0001638599-18-001111, File:https://www.sec.gov/Archives/edgar/data/1682639/000163859918001111/0001638599-18-001111-index.htm $EYENOVIA(EYEN)$
查看全文

EYENOVIA(EYEN) 09月20日 20时18分

查看全文

EYENOVIA(EYEN) 09月20日 20时18分

查看全文

EYENOVIA(EYEN) 09月20日 20时18分

EYENOVIA(EYEN) 09月20日 20时18分

EYENOVIA(EYEN) 09月19日 22时48分

新闻 Eyenovia to Participate in Panel Presentation at OSN New York 2018
CEO Sean Ianchulev to join industry panel discussion on "Medical and Surgical Management of Corneal Conditions and Com ......  url.vc.watch/J97n
查看全文

EYENOVIA(EYEN) 09月19日 01时21分

新闻 Eyenovia to Present at the Ladenburg Thalmann 2018 Healthcare Conference
NEW YORK, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a biopharmaceutical company developing a ......  url.vc.watch/JClv
查看全文

EYENOVIA(EYEN) 08月22日 07时01分

新闻 Eyenovia to Present at the 20th Annual H.C. Wainwright Global Investment Conference
NEW YORK, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a biopharm ......  url.vc.watch/jHw4
查看全文

EYENOVIA(EYEN) 08月17日 06时58分

新闻 ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eyenovia, Inc. and Encourages Investors with Losses in Excess of $100,000 to ......  url.vc.watch/jwjF
查看全文

EYENOVIA(EYEN) 08月16日 07时14分

新闻 INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eyenovia, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact ......  url.vc.watch/jNZ7
查看全文

EYENOVIA(EYEN) 08月16日 04时57分

新闻 Eyenovia to Present at the JMP Securities 2018 Life Sciences Conference
NEW YORK, June 11, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a clinical stage bioph ......  url.vc.watch/jp9y
查看全文

EYENOVIA(EYEN) 08月16日 04时57分

新闻 Eyenovia Appoints Michael Rowe as Vice President of Marketing Ahead of Initiation of Multiple Phase III Programs NEW YORK, July 09, 2018 (GLOBE NEWSWIRE) -- Eyenovia, I ......  url.vc.watch/jp93
查看全文

EYENOVIA(EYEN) 08月16日 04时57分

新闻 Eyenovia Announces Conference Call and Webcast for Second Quarter 2018 Financial Results
NEW YORK, July 31, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a cli ......  url.vc.watch/jp9t
查看全文

EYENOVIA(EYEN) 08月16日 04时57分

新闻 Eyenovia’s EYN PG21 Trial Evaluating High-Precision Microdose of Latanoprost Demonstrates Robust Intraocular Pressure Lowering and Patient Usability Eyenovia's EYN PG21 T ......  url.vc.watch/jp9R
查看全文

EYENOVIA(EYEN) 08月16日 04时57分

新闻 Eyenovia Reports Second Quarter 2018 Financial Results
NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a biopharmaceutical company developing ......  url.vc.watch/jp92
查看全文

EYENOVIA(EYEN) 07月31日 11时27分

公告 EYENOVIA, INC. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:SUN ANTHONY Y
公告日:2018-07-30, 内部交易人:SUN ANTHONY Y, 与发行人关系:董事/, 操作码:A,4033(股)Common Stock, par value $.0001; 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-07-24, SEC Accession No. 0001638599-18-000864, File:https://www.sec.gov/Archives/edgar/data/1682639/000163859918000864/0001638599-18-000864-index.htm $EYENOVIA(EYEN)$
查看全文

EYENOVIA(EYEN) 07月27日 11时26分

公告 EYENOVIA, INC. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:MARIO ERNEST
公告日:2018-07-26, 内部交易人:MARIO ERNEST, 与发行人关系:董事/, 操作码:A,4033(股)Common Stock, par value $.0001; 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-07-24, SEC Accession No. 0001638599-18-000822, File:https://www.sec.gov/Archives/edgar/data/1682639/000163859918000822/0001638599-18-000822-index.htm $EYENOVIA(EYEN)$
查看全文
  • 首页 上一页 1 2 3 下一页 尾页  每页20条/共88